BG107686A - Нови фармацевтични състави, съдържащи епинастин ипсевдоефедрин - Google Patents

Нови фармацевтични състави, съдържащи епинастин ипсевдоефедрин Download PDF

Info

Publication number
BG107686A
BG107686A BG107686A BG10768603A BG107686A BG 107686 A BG107686 A BG 107686A BG 107686 A BG107686 A BG 107686A BG 10768603 A BG10768603 A BG 10768603A BG 107686 A BG107686 A BG 107686A
Authority
BG
Bulgaria
Prior art keywords
layer
pseudoephedrine
pharmaceutically acceptable
effective amount
epinastine
Prior art date
Application number
BG107686A
Other languages
Bulgarian (bg)
English (en)
Inventor
Sara Abelaira
Daniel Bianchi
Francisco Gel
Victor Denker
Mabel Fernandez
VIDAL Marta DE
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG107686(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of BG107686A publication Critical patent/BG107686A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG107686A 2000-10-06 2003-03-28 Нови фармацевтични състави, съдържащи епинастин ипсевдоефедрин BG107686A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121828 2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en) 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine

Publications (1)

Publication Number Publication Date
BG107686A true BG107686A (bg) 2003-11-28

Family

ID=8170029

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107686A BG107686A (bg) 2000-10-06 2003-03-28 Нови фармацевтични състави, съдържащи епинастин ипсевдоефедрин

Country Status (32)

Country Link
EP (1) EP1326586B1 (zh)
JP (1) JP2004521864A (zh)
KR (1) KR20030036894A (zh)
CN (1) CN1291715C (zh)
AR (2) AR032479A1 (zh)
AT (1) ATE424813T1 (zh)
AU (2) AU2002212290B2 (zh)
BG (1) BG107686A (zh)
BR (1) BR0114339A (zh)
CA (1) CA2423288C (zh)
CZ (1) CZ2003945A3 (zh)
DE (1) DE60137952D1 (zh)
EA (1) EA007288B1 (zh)
EC (1) ECSP034513A (zh)
EE (1) EE200300138A (zh)
ES (1) ES2323570T3 (zh)
HK (1) HK1062196A1 (zh)
HR (1) HRP20030259A2 (zh)
HU (1) HUP0300970A3 (zh)
IL (1) IL154884A0 (zh)
ME (1) MEP39708A (zh)
MX (1) MXPA03002900A (zh)
MY (1) MY131159A (zh)
NO (1) NO20031537L (zh)
NZ (1) NZ525653A (zh)
PE (1) PE20020324A1 (zh)
PL (1) PL366123A1 (zh)
SK (1) SK4052003A3 (zh)
UA (1) UA75896C2 (zh)
WO (1) WO2002028373A1 (zh)
YU (1) YU24603A (zh)
ZA (1) ZA200302079B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210534A (pt) * 2001-06-20 2004-06-22 Schering Corp Anti-histaminas para o tratamento de congestão nasal e obstrução nasal
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
CA2494065A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
US20070196396A1 (en) * 2004-02-11 2007-08-23 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
ATE331522T1 (de) * 1997-12-23 2006-07-15 Schering Corp Zusammensetzung zur behandlung von atemwegs- und hauterkrankungen mit mindestens einem leukotrienantagonist und mindestens einem antihistaminikum
CN1329490A (zh) * 1998-10-09 2002-01-02 先灵公司 用于治疗变应性疾病的组合物和方法
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
CZ2003945A3 (cs) 2003-08-13
ES2323570T3 (es) 2009-07-21
HUP0300970A2 (hu) 2003-11-28
KR20030036894A (ko) 2003-05-09
EA007288B1 (ru) 2006-08-25
NO20031537L (no) 2003-06-04
UA75896C2 (en) 2006-06-15
CN1291715C (zh) 2006-12-27
NO20031537D0 (no) 2003-04-04
PL366123A1 (en) 2005-01-24
ZA200302079B (en) 2004-05-05
AR087240A2 (es) 2014-03-12
WO2002028373A1 (en) 2002-04-11
MXPA03002900A (es) 2003-09-10
ATE424813T1 (de) 2009-03-15
AU2002212290B2 (en) 2006-08-03
JP2004521864A (ja) 2004-07-22
CN1468094A (zh) 2004-01-14
CA2423288C (en) 2007-11-13
HK1062196A1 (en) 2004-10-21
EP1326586A1 (en) 2003-07-16
BR0114339A (pt) 2003-12-09
NZ525653A (en) 2006-07-28
YU24603A (sh) 2006-05-25
MY131159A (en) 2007-07-31
HRP20030259A2 (en) 2005-02-28
PE20020324A1 (es) 2002-06-18
MEP39708A (en) 2011-02-10
IL154884A0 (en) 2003-10-31
AU1229002A (en) 2002-04-15
EA200300430A1 (ru) 2003-10-30
ECSP034513A (es) 2003-04-25
EE200300138A (et) 2003-08-15
DE60137952D1 (de) 2009-04-23
SK4052003A3 (en) 2003-09-11
HUP0300970A3 (en) 2005-03-29
CA2423288A1 (en) 2002-04-11
EP1326586B1 (en) 2009-03-11
AR032479A1 (es) 2003-11-12

Similar Documents

Publication Publication Date Title
TW506836B (en) Fast-dissolving galanthamine hydrobromide tablet
EP1468679B1 (en) Controlled release formulation containing tramadol
CZ101495A3 (en) Per os administered preparations with stably maintained release
US7022341B2 (en) Pharmaceutical compositions containing epinastine and pseudoephedrine
EP2243468A1 (en) Orally Disintegrating Dimebolin Compositions
BG107686A (bg) Нови фармацевтични състави, съдържащи епинастин ипсевдоефедрин
US20060193915A1 (en) Compression coated tablets
AU2002212290A1 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
EP1490034B1 (en) Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions
CA2494065A1 (en) Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
US20050171119A1 (en) Pharmaceutical formulations with modified release
AU2004324868B2 (en) High-dosage extended-release formulation of gepirone
EP4205730A1 (en) Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia
EP3087978A1 (en) Sustained-release pharmaceutical composition containing acebrophylline and hydrophillic sustained-release agent
TWI280884B (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
US20060099267A1 (en) High-dosage extended-release formulation of gepirone
KR20070093972A (ko) 게피론의 고용량 서방성 제제
EP2340813A1 (en) Solid dosage formulations of galantamine
NZ554916A (en) High-dosage extended-release formulation of gepirone